U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
160531160531Phenylephrine in Spinal Anesthesia in Preeclamptic PatientsRecruitingNo Results AvailablePreeclampsia|HypotensionDrug: Ephedrine|Drug: Phenylephrinehttps://ClinicalTrials.gov/show/NCT00458003
160532160532Neurodevelopment After Early Iron SupplementationCompletedNo Results AvailableIron Deficiency|Anemia of Prematurity|Neurodevelopmental DelayDrug: Oral administration of ferrous sulphatehttps://ClinicalTrials.gov/show/NCT00457990
160533160533Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary DiseaseCompletedHas ResultsPulmonary Disease, Chronic ObstructiveBiological: Pneumovax (PPSV23)|Biological: Prevnar (PCV7)https://ClinicalTrials.gov/show/NCT00457977
160534160534RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAMCompletedNo Results AvailableTuberous Sclerosis|LymphangioleiomyomatosisDrug: RAD001https://ClinicalTrials.gov/show/NCT00457964
160535160535A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPDTerminatedNo Results AvailableChronic Obstructive Pulmonary DiseaseDrug: Normal Saline infusion|Drug: ODSHhttps://ClinicalTrials.gov/show/NCT00457951
160536160536Novel Therapies for Metabolic Complications of LipodystrophiesRecruitingNo Results AvailableInsulin Resistance|Hypertriglyceridemia|Diabetes|Hepatic SteatosisOther: low-fat diet ( Still recruiting )|Other: Diethttps://ClinicalTrials.gov/show/NCT00457938
160537160537Absorption, Distribution, Metabolism And Excretion Study For GSK221149ACompletedNo Results AvailableObstetric Labour, Premature|Premature LaborDrug: GSK221149Ahttps://ClinicalTrials.gov/show/NCT00457925
160538160538Genetic Characterization of Individuals With Limb Girdle Muscular DystrophyActive, not recruitingNo Results AvailableLimb-Girdle Muscular Dystrophyhttps://ClinicalTrials.gov/show/NCT00457912
160539160539Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective DisorderTerminatedNo Results AvailableSchizophrenia|Schizoaffective Disorders|Psychotic DisordersDrug: Quetiapine IR (Immediate Release)https://ClinicalTrials.gov/show/NCT00457899
160540160540Measurement of Hormone Levels in Patients Receiving 17-HPC for Preterm DeliveryCompletedNo Results AvailablePreterm Delivery.https://ClinicalTrials.gov/show/NCT00457886
160541160541Isotonic Versus Hypotonic Fluid for Maintenance IV TherapyCompletedNo Results AvailableGastroenteritis|Bronchiolitis|Sepsis|Urinary Tract InfectionDrug: 0.9% saline in 5% dextrose (intravenous)|Drug: 0.45% saline in 5% dextrose (intravenous)https://ClinicalTrials.gov/show/NCT00457873
160542160542Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance DiseaseRecruitingNo Results AvailableLeukemiaDrug: Immunotoxin therapy|Drug: CAT-8015 immunotoxin|Procedure: Biological therapyhttps://ClinicalTrials.gov/show/NCT00457860
160543160543Identifying Genetic Characteristics That Increase the Risk of Developing Primary Graft Dysfunction Following Lung TransplantationRecruitingNo Results AvailablePrimary Graft Dysfunction|Lung Transplantationhttps://ClinicalTrials.gov/show/NCT00457847
160544160544Bi-Ventricular Pacing in Patients With Atrial Fibrillation and Heart Failure (BIFF-Study)Active, not recruitingNo Results AvailableHeart FailureDevice: InSync IIIhttps://ClinicalTrials.gov/show/NCT00457834
160545160545Safety Study of Ivacaftor in Subjects With Cystic FibrosisCompletedHas ResultsCystic FibrosisDrug: Ivacaftor 25 mg/75 mg|Drug: Ivacaftor 75 mg/150 mg|Drug: Ivacaftor 150 mg or 250 mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00457821
160546160546Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAMCompletedNo Results AvailableTuberous Sclerosis|LymphangioleiomyomatosisDrug: Rapamycin, sirolimushttps://ClinicalTrials.gov/show/NCT00457808
16054716054724-hour IOP-lowering Effect of Brimonidine 0.1%CompletedHas ResultsOpen-angle Glaucoma|Ocular HypertensionDrug: brimonidine 0.1% (Alphagan® P)https://ClinicalTrials.gov/show/NCT00457795
160548160548A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's LymphomaCompletedNo Results AvailableMultiple Myeloma|Chronic Lymphocytic Leukaemia|Lymphoma, B-CellDrug: KW-2478https://ClinicalTrials.gov/show/NCT00457782
160549160549Aricept to Improve Functional Tasks in Vascular DementiaActive, not recruitingNo Results AvailableStroke|Vascular Dementia|Memory DeficitsDrug: Donepezil|Drug: Donepezilhttps://ClinicalTrials.gov/show/NCT00457769
160550160550The Effect of BiosLife on Serum LipidsCompletedNo Results AvailableHypercholesterolemiaDietary Supplement: BiosLife Complete|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT00457756
160551160551A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST)CompletedHas ResultsGastrointestinal Stromal TumorsDrug: Sunitinib malate (SU011248)https://ClinicalTrials.gov/show/NCT00457743
160552160552A Study to Test the Use of Duloxetine for Pain in MSCompletedHas ResultsMultiple SclerosisDrug: Duloxetine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00457730
160553160553Myopia Control by Combining Auricular Acupoint and Atropine EyedropsCompletedNo Results AvailableMyopiaDrug: 0.25 % atropine|Drug: 0.5 % atropine|Procedure: 0.25 % atropine+auricular acupointshttps://ClinicalTrials.gov/show/NCT00457717
160554160554Carriage and Transmission of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Patients Admitted to Home Care.TerminatedNo Results AvailableMethicillin-Resistant Staphylococcus Aureushttps://ClinicalTrials.gov/show/NCT00457704
160555160555Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal CancerCompletedHas ResultsMetastatic Colorectal CancerDrug: 5 fluorouracil|Drug: irinotecan|Drug: levo- leucovorin|Drug: sunitinib|Drug: 5 fluorouracil|Drug: irinotecan|Drug: levo- leucovorin|Drug: placebohttps://ClinicalTrials.gov/show/NCT00457691
160556160556Second Line Therapy to Treat Age-Related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by ItselfAvailableNo Results AvailableAge Related Macular DegenerationDrug: Visudyne|Drug: Lucentis|Drug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT00457678
160557160557Mechanisms of Lipodystrophy in HIV-Infected PateintsCompletedNo Results AvailableHIV InfectionsDrug: Viracept versus Sustiva with stavudine and epivirhttps://ClinicalTrials.gov/show/NCT00457665
160558160558Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?CompletedNo Results AvailableIschemia Reperfusion InjuryDrug: Rosuvastatinhttps://ClinicalTrials.gov/show/NCT00457652
160559160559Cholic Acid for Hepatic Steatosis in LipodystrophyActive, not recruitingNo Results AvailableHepatic SteatosisDrug: Cholic Acidhttps://ClinicalTrials.gov/show/NCT00457639
160560160560An Open Label Extension Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With HypertensionCompletedNo Results AvailableHypertensionDrug: Valsartanhttps://ClinicalTrials.gov/show/NCT00457626

* Görseller ve İçerik tekif hakkına sahip olabilir